Riluzole Tablet Market
Riluzole Tablet Market Scope: Industry Analysis,
Market Size, Growth, Trends Till 2031
Request Sample Report
Riluzole Tablet Market Size and Growth
The Riluzole Tablet market is experiencing notable growth, driven by rising ALS prevalence and increased awareness of neurological disorders. The global market size is projected to reach USD 2 billion by 2028, with a CAGR of 6%. Competitive dynamics include evolving formulations and expanding distribution channels to enhance accessibility.
Companies Covered
(Covid 19 Impact Covered)
◍ Sanofi
◍ Mylan Pharma
◍ Apotex
◍ Glemark Generics
◍ Covis Pharma
◍ Sun Pharma
◍ Lunan Pharma
◍ Italfarmaco
The Riluzole Tablet Market features key players like Sanofi, Mylan Pharma, Apotex, Glenmark Generics, Covis Pharma, Sun Pharma, and Lunan Pharma. These companies drive market growth through innovative formulations, strategic partnerships, competitive pricing, and expanded distribution, enhancing accessibility and affordability of Riluzole for ALS treatment. Specific revenue figures are proprietary.
Request Sample Report
Market Segmentation
By Application
Hospital
Pharmacy
Request Sample Report
By Product
With Film-coated
Without Film-coated
$ 36.00 Million
Request Sample Report
